Eric Distad

Company: Cerebral Therapeutics

Job title: Vice President, Clinical Development

Seminars:

11.00 Long-Term Chronic Delivery of VPA to the ICV: A Safety Summary 11:00 am

A delivery system of including implanted drug pump and intracranial catheter was accomplished safely in 27 subjects The intracranial catheter could be implanted on target Long-term delivery of the drug to the ICV was safe with no adverse anatomical or toxicity signalsRead more

day: Day One Track 2 AM

12.00 Presenter Q+A & Audience Discussion 12:00 pm

What must be done to transform the clinical scalability of these technologies through phase I & beyond?Read more

day: Day One Track 2 AM